JACC publishes groundbreaking research on HCM utilising AI

MyCardium AI can announce a significant milestone in cardiology innovation with the publication of cutting-edge research in the Journal of the American College of Cardiology (JACC). This study, led by Hunain Shiwani and supported by the expertise of Rhodri Davies from UCL, highlights the transformative potential of artificial intelligence in redefining how hypertrophic cardiomyopathy (HCM) is diagnosed.

The AI technology powering this breakthrough, initially developed at University College London is now seamlessly integrated into MyCardium AI’s 1CMRPro software and Core Lab. It leverages advanced algorithms to challenge long-standing definitions of left ventricular hypertrophy (LVH) that have remained unchanged since the 1970s.

Advancing Personalised Cardiac Care

The study focuses on tailoring the definition of LVH to consider critical patient-specific factors such as age, sex, and body size. This refined approach addresses inherent biases in traditional diagnostic criteria, which have historically limited the identification of HCM, particularly in women. By advancing a more personalised and equitable definition of LVH, the research lays the foundation for improved diagnostic accuracy and therapeutic strategies in modern cardiology.

Implications for the Future of HCM Diagnosis

Hypertrophic cardiomyopathy, a condition affecting the structure and function of the heart, can lead to severe complications if left undiagnosed. MyCardium AI’s innovative algorithms provide clinicians with tools to identify HCM more effectively, offering significant benefits in early detection, risk stratification, and individualised treatment planning.

Professor James Moon, CEO of MyCardium AI, remarked:
"This study exemplifies the power of AI in challenging outdated medical paradigms and driving precision medicine forward. We are incredibly proud to see 1CMRPro and the MyCardium Core Lab play a pivotal role in shaping the future of cardiac diagnostics.”

Bridging Research and Practice

This landmark research underscores MyCardium AI's mission to integrate state-of-the-art technology with clinical expertise to drive advancements in cardiovascular care. By addressing disparities and enhancing diagnostic frameworks, MyCardium AI continues to pioneer solutions that improve patient outcomes globally.

The full research article is available to read here, with an accompanying editorial here.